170 related articles for article (PubMed ID: 21703734)
21. Dual aromatase-steroid sulfatase inhibitors.
Woo LW; Bubert C; Sutcliffe OB; Smith A; Chander SK; Mahon MF; Purohit A; Reed MJ; Potter BV
J Med Chem; 2007 Jul; 50(15):3540-60. PubMed ID: 17580845
[TBL] [Abstract][Full Text] [Related]
22. Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer.
Nagar S; Saha A
J Comput Chem; 2010 Sep; 31(12):2342-53. PubMed ID: 20340106
[TBL] [Abstract][Full Text] [Related]
23. Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells.
Sanderson JT; Hordijk J; Denison MS; Springsteel MF; Nantz MH; van den Berg M
Toxicol Sci; 2004 Nov; 82(1):70-9. PubMed ID: 15319488
[TBL] [Abstract][Full Text] [Related]
24. New 7,8-benzoflavanones as potent aromatase inhibitors: synthesis and biological evaluation.
Yahiaoui S; Fagnere C; Pouget C; Buxeraud J; Chulia AJ
Bioorg Med Chem; 2008 Feb; 16(3):1474-80. PubMed ID: 18042388
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antimycobacterial activity of pyridylmethylsulfanyl and naphthylmethylsulfanyl derivatives of benzazoles, 1, 2, 4-triazole, and pyridine-2-carbothioamide/-2-carbonitrile.
Zahajská L; Klimesová V; Kocí J; Waisser K; Kaustová J
Arch Pharm (Weinheim); 2004 Oct; 337(10):549-55. PubMed ID: 15476287
[TBL] [Abstract][Full Text] [Related]
26. Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors.
Yahiaoui S; Pouget C; Buxeraud J; Chulia AJ; Fagnère C
Eur J Med Chem; 2011 Jun; 46(6):2541-5. PubMed ID: 21497425
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives.
Sztanke K; Tuzimski T; Rzymowska J; Pasternak K; Kandefer-Szerszeń M
Eur J Med Chem; 2008 Feb; 43(2):404-19. PubMed ID: 17531354
[TBL] [Abstract][Full Text] [Related]
28. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
[TBL] [Abstract][Full Text] [Related]
29. Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis.
Bilotas M; Meresman G; Stella I; Sueldo C; Barañao RI
Fertil Steril; 2010 May; 93(8):2513-8. PubMed ID: 19819437
[TBL] [Abstract][Full Text] [Related]
30. Discovery of a new class of cinnamyl-triazole as potent and selective inhibitors of aromatase (cytochrome P450 19A1).
McNulty J; Keskar K; Crankshaw DJ; Holloway AC
Bioorg Med Chem Lett; 2014 Sep; 24(18):4586-4589. PubMed ID: 25155384
[TBL] [Abstract][Full Text] [Related]
31. Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach.
Itoh T; Karlsberg K; Kijima I; Yuan YC; Smith D; Ye J; Chen S
Mol Cancer Res; 2005 Apr; 3(4):203-18. PubMed ID: 15831674
[TBL] [Abstract][Full Text] [Related]
32. Direct spectroscopic evidence for binding of anastrozole to the iron heme of human aromatase. Peering into the mechanism of aromatase inhibition.
Maurelli S; Chiesa M; Giamello E; Di Nardo G; Ferrero VE; Gilardi G; Van Doorslaer S
Chem Commun (Camb); 2011 Oct; 47(38):10737-9. PubMed ID: 21858332
[TBL] [Abstract][Full Text] [Related]
33. Effects of letrozole on proliferation and apoptosis in cultured leiomyoma cells treated with prostaglandin E(2).
Han M; Kim JY; Park JE; Kim JM; Lee KS
Eur J Obstet Gynecol Reprod Biol; 2008 May; 138(1):83-8. PubMed ID: 18164802
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and cytotoxic activities of novel hybrid 2-phenyl-3-alkylbenzofuran and imidazole/triazole compounds.
Chen W; Deng XY; Li Y; Yang LJ; Wan WC; Wang XQ; Zhang HB; Yang XD
Bioorg Med Chem Lett; 2013 Aug; 23(15):4297-302. PubMed ID: 23800685
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors.
Ammazzalorso A; Gallorini M; Fantacuzzi M; Gambacorta N; De Filippis B; Giampietro L; Maccallini C; Nicolotti O; Cataldi A; Amoroso R
Eur J Med Chem; 2021 Feb; 211():113115. PubMed ID: 33360796
[TBL] [Abstract][Full Text] [Related]
36. Steroidal pyrazolines evaluated as aromatase and quinone reductase-2 inhibitors for chemoprevention of cancer.
Abdalla MM; Al-Omar MA; Bhat MA; Amr AG; Al-Mohizea AM
Int J Biol Macromol; 2012 May; 50(4):1127-32. PubMed ID: 22361454
[TBL] [Abstract][Full Text] [Related]
37. New Potent 5α- Reductase and Aromatase Inhibitors Derived from 1,2,3-Triazole Derivative.
El-Naggar M; El-All ASA; El-Naem SIA; Abdalla MM; Rashdan HRM
Molecules; 2020 Feb; 25(3):. PubMed ID: 32033281
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and evaluation of novel 16-imidazolyl substituted steroidal derivatives possessing potent diversified pharmacological properties.
Bansal R; Guleria S; Thota S; Bodhankar SL; Patwardhan MR; Zimmer C; Hartmann RW; Harvey AL
Steroids; 2012 May; 77(6):621-9. PubMed ID: 22366075
[TBL] [Abstract][Full Text] [Related]
39. The synthesis and biological evaluation of some caffeic acid amide derivatives: E-2-cyano-(3-substituted phenyl)acrylamides.
Zhou W; Li HB; Xia CN; Zheng XM; Hu WX
Bioorg Med Chem Lett; 2009 Apr; 19(7):1861-5. PubMed ID: 19272773
[TBL] [Abstract][Full Text] [Related]
40. Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors.
Neves MA; Dinis TC; Colombo G; Sá e Melo ML
J Med Chem; 2009 Jan; 52(1):143-50. PubMed ID: 19072235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
